Thrombosis
From the Journals
Large study finds trans men on testosterone at risk for blood clots
Transgender men who take testosterone are at risk of developing erythrocytosis and future thrombotic events, especially if they smoke and are...
News from the FDA/CDC
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)
Completed safety clinical trial shows occurrence of heart-related events and cancer in RA patients taking the Janus kinase inhibitor is higher...
From the Journals
Microthrombi, necrosis seen in COVID-19 hearts on autopsy
A new autopsy series shows microthrombi and focal necrosis in hearts of patients who died of COVID-19. The findings support use of anticoagulation...
Feature
Full-dose anticoagulation reduces need for life support in COVID-19
Conference Coverage
In COVID-19 patients, risk of bleeding rivals risk of thromboembolism
Conference Coverage
A 4-point thrombocytopenia score was found able to rule out suspected HIT
From the Journals
DOACs look safe in elective endoscopic procedures
The study also found delaying resumption of anticoagulants provided no benefit.
From the Journals
NETs a possible therapeutic target for COVID-19 thrombosis?
Feature
COVID-19 anticoagulation trials ‘paused’ for futility, safety
The trials involved are the REMAP-CAP, ACTIV-4, and ATTACC studies.
Opinion
ASH guidelines for venous thromboembolism: What family physicians need to know
A recommendation regarding the use of DOACs may ease some of the burden of monitoring patients on long-term Coumadin.
From the Journals
COVID-19 and risk of clotting: ‘Be proactive about prevention’
"We believe a systematic way of addressing this risk is best, with every patient hospitalized with COVID-19 receiving some type of...